Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICATE: Early Prednisolone for Suspected Community-acquired Acute Respiratory Tract Infection
NCT06472219Phase 3Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in acute respiratory tract infection (ARTI), sponsored by The University of Hong Kong. Started Dec 2024; status: recruiting.
02
Drugs
prednisolone
03
Conditions
acute respiratory tract infection (ARTI)
Beyond the preview
Go deeper on NCT06472219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06472219.